Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

Clinical trial NCT05665374 · COMPLETED

Trial details

NCT number: NCT05665374
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)

Start date: 2023-06-19
Primary completion: 2025-08-20
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.